Deerfield Management Company,
$8.0B 13F equity value
84 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Deerfield Management Company, covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NUVL | NUVALENT INC | 17,248,450 | $2.1B | 26.5% |
| RVMD | REVOLUTION MEDICINES INC | 2,392,000 | $448M | 5.6% |
| PRAX | PRAXIS PRECISION MEDICINES I | 963,351 | $323M | 4.0% |
| VTRS | VIATRIS INC | 20,206,170 | $321M | 4.0% |
| CNC | CENTENE CORP DEL | 4,901,000 | $315M | 3.9% |
| UTHR | UNITED THERAPEUTICS CORP DEL | 457,000 | $248M | 3.1% |
| LEGN | LEGEND BIOTECH CORP | 8,137,638 | $235M | 2.9% |
| COGT | COGENT BIOSCIENCES INC | 5,006,104 | $194M | 2.4% |
| GMAB | GENMAB A/S | 6,865,000 | $189M | 2.3% |
| BKD | BROOKDALE SR LIVING INC | 11,637,032 | $187M | 2.3% |
Track Deerfield Management Company,'s 13F portfolio: $8.0B in reported holdings, 84 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}